Veritable’s Sabra Healthcare REIT SBRA Stock Holding History

Veritable’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,951	Closed	-$181K	–	878
2022 Q2	$181K	Buy	+12,951	New	+$173K	﹤0.01%	835

Other funds holding SBRA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $9.67B AUM 5.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Veritable's SBRA Position: Q3 2022 in Review

Veritable sold out of Sabra Healthcare REIT (SBRA) in Q3 2022, closing a stake of 12,951 shares — an estimated $181K sold.

Veritable first reported a position in SBRA in Q2 2022 and held it in 1 quarter. The position peaked at $181K in Q2 2022. 332 funds tracked by Wall St. Rank hold SBRA as of Q3 2022.

Veritable reported no remaining Sabra Healthcare REIT position as of Q3 2022 after selling out during the quarter.
Veritable sold 12,951 Sabra Healthcare REIT shares in Q3 2022, an estimated $181K.
Veritable first reported a position in Sabra Healthcare REIT in Q2 2022 and held it in 1 quarter.
Veritable's Sabra Healthcare REIT position peaked at $181K in Q2 2022.
332 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2022.

Based on Veritable's 13F filing for Q3 2022, filed 14 Nov 2022.